Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOL-005 Intradermal Injection for Hair Growth in Alopecia
NCT03467412Phase 2Completed
- Sponsor
- Follicum
- Start
- Feb 2018
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Follicopeptide in androgenetic alopecia (AGA), sponsored by Follicum. Started Feb 2018; status: completed.
02
Drugs
Follicopeptide
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT03467412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467412.